Palbociclib: Safe and Effective in an 85-Year-Old Female with Metastatic Bilateral Breast Cancer

J Coll Physicians Surg Pak. 2024 Feb;34(2):249-250. doi: 10.29271/jcpsp.2024.02.249.

Abstract

Null.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Piperazines / therapeutic use
  • Pyridines / therapeutic use
  • Receptor, ErbB-2

Substances

  • palbociclib
  • Pyridines
  • Piperazines
  • Receptor, ErbB-2